SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
SRTS reported Third Quarter 2026 results. The price and volatility reaction is pending.
SRTSearnings

Earnings reactions, page 3

Sensus Healthcare, Inc. (SRTS) Q3 FY2026 earnings

November 13, 2026 · SharpeIQ Research Desk

Reported results

  • Revenues were $6.0 million for the third quarter of 2026, compared with $6.9 million for the third quarter of 2025.
  • GAAP net loss was $1.5 million, or $0.09 per share, for the third quarter of 2026, compared with GAAP net loss of $0.9 million, or $0.06 per share, for the third quarter of 2025.
  • Gross profit was $3.3 million and gross margin was 55% for the third quarter of 2026, compared to gross profit of $2.7 million and gross margin of 39.1% for the third quarter of 2025.
  • Non-GAAP Adjusted EBITDA was negative $1.5 million for the third quarter of 2026, compared with negative $2.4 million for the third quarter of 2025.
  • Unit shipments increased year-over-year to 26 systems for the third quarter of 2026 compared with 16 systems in the prior-year period.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →